We are live on ! Find out more
LMNL

Liminal BioSciences Inc. Common Shares
LMNL

Delisted

LMNL was delisted on the 25th of September, 2023.

Back to rankings

14 hedge funds and large institutions have $35.8M invested in Liminal BioSciences Inc. Common Shares in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 14 → 14 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

3% less capital invested

Capital invested by funds: $36.8M → $35.8M (-$983K)

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

Holders
14
Holders Change
–
Holders Change %
0%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AI
Atom Investors
Texas
+$385K
2
VF
Virtu Financial
New York
+$200K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$180K
4
JP Morgan Chase
JP Morgan Chase
New York
+$41.8K
5
UBS Group
UBS Group
Switzerland
+$10.7K

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$2.74M
2
Morgan Stanley
Morgan Stanley
New York
-$470K
3
Citadel Advisors
Citadel Advisors
Florida
-$118K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$106K
5
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$11.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
CCM
1
Consonance Capital Management
New York
$34.3M -$2.74M -20,268 -6%
AI
2
Atom Investors
Texas
$590K +$385K +2,848 +116%
FDCDDQ
3
Federation des caisses Desjardins du Quebec
Quebec, Canada
$436K -$11.2K -83 -2%
VF
4
Virtu Financial
New York
$164K +$200K +1,477 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$147K +$180K +1,329 New
Royal Bank of Canada
6
Royal Bank of Canada
Ontario, Canada
$60K -$106K -787 -59%
JP Morgan Chase
7
JP Morgan Chase
New York
$32K +$41.8K +309 New
Morgan Stanley
8
Morgan Stanley
New York
$19K -$470K -3,474 -95%
UBS Group
9
UBS Group
Switzerland
$9K +$10.7K +79 +7,900%
TRCT
10
Tower Research Capital (TRC)
New York
$4K -$4.06K -30 -43%
Toronto Dominion Bank
11
Toronto Dominion Bank
Ontario, Canada
$4K +$1.35K +10 +77%
RE
12
RBC Europe
United Kingdom
$2.6K – – –
Bank of Montreal
13
Bank of Montreal
Ontario, Canada
$1K -$1.76K -13 -46%
Citadel Advisors
14
Citadel Advisors
Florida
– -$118K -1,130 Closed
Bank of America
15
Bank of America
North Carolina
– -$1K -13 Closed

LMNL Hedge Fund Activity: Q3 2020 in Review

14 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Liminal BioSciences Inc. Common Shares (LMNL) for Q3 2020, worth a combined $35.8M — down 2.7% from $36.8M a quarter earlier.

Fund positioning in LMNL was balanced in Q3 2020: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 6 trimmed.

The largest buyer was Atom Investors, adding an estimated $385K. The largest seller was Consonance Capital Management, cutting an estimated $2.74M.

  • 14 institutional investors held Liminal BioSciences Inc. Common Shares (LMNL) as of Q3 2020, unchanged from Q2 2020.
  • Funds reported $35.8M of Liminal BioSciences Inc. Common Shares stock for Q3 2020, down 2.7% quarter-over-quarter.
  • 3 funds opened new Liminal BioSciences Inc. Common Shares positions in Q3 2020 and 3 closed out, a net change of 0 holders.
  • The largest Liminal BioSciences Inc. Common Shares buyer in Q3 2020 was Atom Investors, an estimated $385K added.
  • The largest Liminal BioSciences Inc. Common Shares seller in Q3 2020 was Consonance Capital Management, an estimated $2.74M sold.

Based on aggregated 13F filings for Q3 2020.